News
Celsius (NASDAQ:CELH) reported Q2 2025 GAAP revenue and non-GAAP earnings that surpassed consensus analyst estimates by wide margins. The Alani Nu acquisition contributed $301.2 million in revenue ...
'Celsius has an ingredient known to flag as cocaine in MLB drug testing, and although it's not officially banned, it's strongly discouraged,' the reporter wrote in a now-deleted X post.
CELH's energy-fueled innovation and PEP's global scale show rising momentum. But which beverage stock leads now?
StockStory.org on MSN1d
Celsius (NASDAQ:CELH) Reports Upbeat Q2, Stock Jumps 16.7%
Energy drink company Celsius (NASDAQ:CELH) announced in Q2 CY2025, with sales up 83.9% year on year to $739.3 million. Its ...
A viral claim suggesting that Celsius energy drinks can cause false positives for cocaine in drug tests has sparked widespread confusion. The controversy began when a Detroit Tigers sports ...
Q2 2025 Earnings Call Transcript August 7, 2025 Celsius Holdings, Inc. beats earnings expectations. Reported EPS is $0.33, expectations were $0.23. Operator: Good morning, and welcome to the Celsius ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results